Therapeutic drug monitoring in children and adolescents with schizophrenia-spectrum, affective, behavioural, tic and other psychiatric disorders treated with aripiprazole: results of the TDM-VIGIL pharmacovigilance study.
Riegger J, Egberts KM, Clement HW, Schneider-Momm K, Taurines R, Fekete S, Wewetzer C, Karwautz A, Correll CU, Plener PL, Malzahn U, Heuschmann P, Unterecker S, Scherf-Clavel M, Rock H, Antony G, Briegel W, Banaschewski T, Hellenschmidt T, Kaess M, Kölch M, Renner T, Rexroth C, Schulte-Körne G, Walitza S, Gerlach M, Romanos M, Fleischhaker C.
Riegger J, et al. Among authors: renner t.
J Neural Transm (Vienna). 2024 Nov 2. doi: 10.1007/s00702-024-02819-6. Online ahead of print.
J Neural Transm (Vienna). 2024.
PMID: 39487894